BRENNER RANDALL B. (Chief Development & Regulatory) sold 5.3% of their position (19.61K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $52.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2022ACC: 0000904454-22-000425
Officer· Chief Development & Regulatory
Since Sep 2019
+28.12K
Net shares
Net buyer
$52.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
47.73K acquired · 19.61K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+47.73K
Price / share
—
Trade value
—
% of position
14.9%
8/8/2022
321.03K→368.76K
Common Stock
Direct
Shares
−19.61K
Price / share
$2.66
Trade value
$52.16K
% of position
5.3%
8/9/2022
368.76K→349.15K
Total
Net shares
+28.12K
Net value
-$52.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2022 | A · Award | +47.73K | — | — | 14.9% | 321.03K | 368.76K |
| Common Stock Direct | 8/9/2022 | S · Sale | −19.61K | $2.66 | $52.16K | 5.3% | 368.76K | 349.15K |
| Total | +28.12K | -$52.16K | ||||||
Derivative Transactions0
No derivative transactions reported